MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. The company is headquartered in Geneve, Geneve. The company went IPO on 2011-09-19. The firm acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The firm also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.

Industry: Pharmaceutical Preparations Peers: AC Immune SA ADC Therapeutics SA CRISPR Therapeutics AG VectivBio Holding AG